Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$1.45B |
| 2 |
CVS Health
CVS
|
+$1.29B |
| 3 |
Norfolk Southern
NSC
|
+$619M |
| 4 |
Johnson Controls International
JCI
|
+$359M |
| 5 |
Coupang
CPNG
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$1.47B |
| 2 |
Wells Fargo
WFC
|
+$1.35B |
| 3 |
GE Aerospace
GE
|
+$944M |
| 4 |
Hewlett Packard
HPE
|
+$880M |
| 5 |
Microchip Technology
MCHP
|
+$738M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.14% |
| 2 | Financials | 20.84% |
| 3 | Technology | 12.56% |
| 4 | Communication Services | 12.34% |
| 5 | Industrials | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Broadcom
AVGO
$1.77T
| $6.11M | ﹤0.01% |
38,080
-11,500
| -23% | -$1.61M |
|
127
IBM
IBM
$225B
| $5.93M | ﹤0.01% |
34,270
| – | – |
|
128
Dell
DELL
$305B
| $5.3M | ﹤0.01% |
38,400
-25,150
| -40% | -$3.37M |
|
129
Berkshire Hathaway Class B
BRK.B
$1.08T
| $5.17M | ﹤0.01% |
12,703
-117
| -0.9% | -$47.8K |
|
130
Apple
AAPL
$4.59T
| $5.12M | ﹤0.01% |
24,318
-38
| -0.2% | -$7.09K |
|
131
Deere & Co
DE
$168B
| $4.87M | ﹤0.01% |
13,036
-125
| -0.9% | -$48.8K |
|
132
Amgen
AMGN
$236B
| $4.49M | ﹤0.01% |
14,382
| – | – |
|
133
Shell
SHEL
$250B
| $4.17M | ﹤0.01% |
57,713
-500
| -0.9% | -$35.7K |
|
134
Danaher
DHR
$152B
| $4.13M | ﹤0.01% |
16,525
| – | – |
|
135
Cemex
CX
$15.8B
| $4.12M | ﹤0.01% |
644,700
+31,500
| +5% | +$241K |
|
136
Motorola Solutions
MSI
$80.5B
| $3.33M | ﹤0.01% |
8,627
| – | – |
|
137
Pfizer
PFE
$160B
| $3.24M | ﹤0.01% |
115,935
-450
| -0.4% | -$12.4K |
|
138
Johnson & Johnson
JNJ
$640B
| $3.08M | ﹤0.01% |
21,097
| – | – |
|
139
Halliburton
HAL
$29.6B
| $2.95M | ﹤0.01% |
87,202
-5,200
| -6% | -$192K |
|
|
140
Berkshire Hathaway Class A
BRK.A
$1.08T
| $2.45M | ﹤0.01% |
4
| – | – |
|
141
S&P Global
SPGI
$128B
| $2.41M | ﹤0.01% |
5,400
| – | – |
|
142
PNC Financial Services
PNC
$97.1B
| $2.22M | ﹤0.01% |
14,275
| – | – |
|
143
APA Corp
APA
$14.8B
| $2.14M | ﹤0.01% |
72,850
-6,500
| -8% | -$201K |
|
144
Otis Worldwide
OTIS
$27.2B
| $2.1M | ﹤0.01% |
21,810
-450
| -2% | -$43.4K |
|
145
Alpha and Omega Semiconductor
AOSL
$794M
| $1.89M | ﹤0.01% |
50,694
+2,601
| +5% | +$68.7K |
|
146
AbbVie
ABBV
$456B
| $1.89M | ﹤0.01% |
11,006
| – | – |
|
147
Corning
GLW
$132B
| $1.87M | ﹤0.01% |
48,150
-7,050
| -13% | -$246K |
|
148
Abbott
ABT
$193B
| $1.86M | ﹤0.01% |
17,857
| – | – |
|
149
Philip Morris
PM
$297B
| $1.72M | ﹤0.01% |
17,000
| – | – |
|
150
Honeywell
HON
$69.9B
| $1.71M | ﹤0.01% |
8,508
| – | – |
|
Similar funds
Dodge & Cox's Q2 2024 Portfolio in Review
As of Q2 2024, Dodge & Cox held 205 positions worth $167B, down 3.3% from $172B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 4.4%. Dodge & Cox opened 6 new positions and exited 3, leaving the 205-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
- Dodge & Cox's largest Q2 2024 buy was Humana: 4,308,536 shares worth $1.61B.
- Dodge & Cox added most to CVS Health in Q2 2024, an estimated $1.29B increase.
- Dodge & Cox's biggest Q2 2024 reduction was Cigna, cutting an estimated $1.47B.
- Dodge & Cox fully exited Ovintiv in Q2 2024, selling an estimated $450M.
- Dodge & Cox's ten largest holdings make up 30% of its $167B portfolio in Q2 2024.
- Dodge & Cox opened 6 new positions and closed 3 in Q2 2024.
- Dodge & Cox's portfolio value fell 3.3% quarter-over-quarter to $167B.
Based on Dodge & Cox's 13F filing for Q2 2024, filed 13 Aug 2024.